2017
-
Roles for rheumatology staff evolve as MACRA takes effect
All healthcare professionals who work in rheumatology had to start adapting to a new landscape of reporting and documentation on Jan. 1 of this year, when the Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act, or MACRA, began. As the changeover continues, the…
-
ARHP session covers latest news regarding new medications, safety
An ARHP session on Monday will offer attendees the latest information on new medications, new indications, safety issues, and FDA action on biosimilars over the past year. The session, Pharma Update: Safety, New Indications, Latest Approvals, will be held from 2:30 – 3:30 pm in…
-
FDA to provide update about latest treatment approvals
Safety is a constant concern in treating rheumatologic diseases, and new data can impact the risk profile and use of accepted treatments from year to year. Monday’s FDA Update on Safety Issues in the Treatment of Rheumatic Diseasesession will provide the latest in safety of…
-
Presenters to offer tips, tools for improving science education
The practicing rheumatologist needs a basic understanding of the scientific principles that underlie autoimmune and inflammatory disorders. However, as both basic and clinical science knowledge grows, incorporating science material into undergraduate and graduate medical education is becoming increasingly more challenging. Spicing up Science Education: How…
-
Mobility matters for older rheumatology patients’ quality of life, health
Older adults, for whom mobility is critical to maintain independence, make up a significant percentage of the patients cared for by rheumatologists. Those who lose independence are less likely to remain in the community and have higher rates of morbidity, mortality, and self-care disability while…
-
Experts to examine the role of chondrocytes in cartilage damage and osteoarthritis
It is increasingly recognized that changes in chondrocyte phenotypes play an active role in the response of cartilage to injury and in the pathogenesis of osteoarthritis (OA). The symposium Chondrocytes: To Live or Let Die? on Sunday will examine the role of chondrocytes in cartilage damage…
-
Treat-to-target concept emerges in managing osteoporosis, fracture risk for patients
A panel will update attendees Monday on various bone-related disease issues, including current and investigational medications for treatment of osteoporosis, pediatric bone disease and its progression into adulthood, and osteonecrosis in patients with rheumatic disease. During Throw Me a Bone!: Update on Important Concepts in…
-
Reducing inflammation may reduce risk of CV disease in RA patients
A session on Monday will explore the effect of rheumatoid arthritis (RA) disease activity on cardiovascular disease (CVD) outcomes in patients with RA. Joan M. Bathon, MD, Professor of Medicine and Chief of Rheumatology at Columbia University Medical Center in New York, will discuss the…
-
Advances in metabolic research offer new insight into rheumatic diseases
Recent research findings provide new information about how adiposity leads to a systemic inflammatory state and to metabolic derangement, the relationship between osteoarthritis (OA), metabolic signaling and adipokines, and metabolic profiling in rheumatoid arthritis (RA) patients. Experts will discuss the current understanding of metabolic syndrome…
-
Targeted immunotherapy advances demonstrate potential for treating autoimmune diseases
A pair of experts on Monday afternoon will update attendees with new information on the dysregulation of cell processes related to malignancy and inflammation and the development of novel targeted immunotherapy for autoimmune diseases. The ACR basic science symposium Science of Novel Immunotherapy will be…